Dr. Irene Barbazetto - MD

Dr. Irene Barbazetto - MD


  • 460 Park Avenue
  • 5th Floor
  • New York, NY  10022
  •  (212) 861-9797/ Phone

Practice Name:

Vitreous Retina Macula Consultants of New York

See below for the Doctor's other office locations.

Specialties:

  • Ophthalmologist

Department:

  • Ophthalmology

Job Title:

  • Associate Adjunct Surgeon

Professional Statement:

Irene A. Barbazetto, M.D., joined the Vitreous-Retina-Macula Consultants of New York in 2009. She is a board certified vitreoretinal surgeon and macular disease specialist in the Unites States and Germany.

Dr. Barbazetto is a graduate of Hamburg University, Germany where she completed ... more...

Education:

  • University of Hamburg (Medical School)
  • NewYork-Presbyterian Hospital / Columbia University Medical Center, Residency in Ophthalmology
  • Lenox Hill Hospital, Internship in General Surgery
  • Columbia University, Manhattan Eye, Ear and Throat Hospital, Fellowship in Medical and Surgical Vitreoretinal Disease

Languages Spoken:

  • English
  • German

Board Certifications:

  • American Board of Ophthalmology

Professional Memberships:

  • American Society of Retina Specialists
  • Association for Research in Vision and Ophthalmology
  • American Association of Retina Specialists
  • American Academy of Ophthalmology
  • European Association for Vision and Eye Research
  • NY State Ophthalmological Society

Awards and Publications:

  • 2009 Achievement Award from the American Academy of Ophthalmology
  • Achievement Award American Academy of Ophthalmology 2009
  • Barbazetto, I., Chang, L., Slakter J. “Chapter 4: Imaging modalities” in “AMD: State of the Art”. Editor Kaiser, P. Remedica, London, UK, 1st Edition, 2011.
  • More than 40 peer-revied publications
  • Barbazetto, I., Klais, C. “Anecortave Acetate” in “Anti-Angiogenese”. Editor Michels, S. Uni-Med Verlag, Germany, 1st Edition, 2007
  • Lawrence Travel Award 2001
  • Barbazetto I, Saroj N, Shapiro H, Wong P, Freund KB. Dosing regimen and the frequency of macular hemorrhages in neovascular age-related macular degeneration treated with ranibizumab. Retina. 2010 Oct;30(9):1376-85.
  • Patient's Choice Award 2010

States Where Licensed:

  • New York